Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy

Clinical trial NCT01051063 · COMPLETED

Trial details

NCT number: NCT01051063
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukaemia, Myelocytic, Acute

Start date: 2009-12-09
Primary completion: 2016-04-26
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.